An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143

Clinical trial NCT05199610 · COMPLETED

Trial details

NCT number: NCT05199610
Sponsor: EQRx International, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hepatic Impairment

Start date: 2022-03-30
Primary completion: 2023-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.